VJHemOnc is committed to improving our service to you

ESH AL 2020 | Impacts and effects of CAR T-cell therapy for pediatric ALL

VJHemOnc is committed to improving our service to you

Christina Peters

Christina Peters, MD, St. Anna Children’s Hospital, Vienna, Austria, discusses the use of tisagenlecleucel CAR T-cell therapy for relapsed/refractory children and young adults with acute lymphoblastic leukemia (ALL). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter